Crescent Biopharma, Inc. (CBIO)
18.51
+0.58
(+3.23%)
USD |
NASDAQ |
Sep 02, 16:00
18.51
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Total Assets (Quarterly) : 182.76M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 182.76M |
| March 31, 2026 | 199.13M |
| December 31, 2025 | 240.29M |
| September 30, 2025 | 138.27M |
| June 30, 2025 | 157.43M |
| March 31, 2025 | 5.992M |
| December 31, 2024 | 11.09M |
| September 30, 2024 | 15.70M |
| June 30, 2024 | 24.42M |
| March 31, 2024 | 34.20M |
| December 31, 2023 | 45.32M |
| September 30, 2023 | 53.20M |
| June 30, 2023 | 61.82M |
| March 31, 2023 | 68.92M |
| December 31, 2022 | 51.81M |
| September 30, 2022 | 55.96M |
| June 30, 2022 | 65.04M |
| March 31, 2022 | 81.46M |
| December 31, 2021 | 94.35M |
| September 30, 2021 | 107.94M |
| June 30, 2021 | 124.38M |
| March 31, 2021 | 138.02M |
| December 31, 2020 | 142.83M |
| September 30, 2020 | 150.42M |
| June 30, 2020 | 158.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 162.10M |
| December 31, 2019 | 167.97M |
| September 30, 2019 | 180.45M |
| June 30, 2019 | 192.33M |
| March 31, 2019 | 204.44M |
| December 31, 2018 | 214.84M |
| September 30, 2018 | 225.17M |
| June 30, 2018 | 235.70M |
| March 31, 2018 | 247.42M |
| December 31, 2017 | 128.58M |
| September 30, 2017 | 115.82M |
| June 30, 2017 | 121.62M |
| March 31, 2017 | 37.17M |
| December 31, 2016 | 42.39M |
| September 30, 2016 | 48.01M |
| June 30, 2016 | 55.77M |
| March 31, 2016 | 40.70M |
| December 31, 2015 | 48.46M |
| September 30, 2015 | 55.74M |
| June 30, 2015 | 62.04M |
| March 31, 2015 | 48.46M |
| December 31, 2014 | 57.26M |
| September 30, 2014 | 62.43M |
| June 30, 2014 | 67.52M |
| March 31, 2014 | 58.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Encompass Health Corp. | 7.458B |
| Myriad Genetics, Inc. | 638.90M |
| BioRestorative Therapies, Inc. | 4.640M |
| U.S. Stem Cell, Inc. | -- |
| Marijuana, Inc. | 14.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.50M |
| Shareholders Equity (Quarterly) | 163.26M |
| Debt to Equity Ratio | 0.0088 |
| Current Ratio | 9.657 |
| Net Debt Paydown Yield | -0.06% |